Gastroenterology

Diabetes Solution Richard K. Bernstein, MD, FACE, FACN, FACCWS Part 10 Chapter 22 Gastroparesis Modifications of Preprandial or ISA Regimens to Accommodate Gastroparesis It takes a while for your physician to select and fine-tune a program to improve stomach-emptying. In the meantime, it’s possible to reduce the frequency and severity ...

New evidence suggests surgery has glucose benefits beyond weight reduction effects… A decrease in blood sugar values after gastric bypass surgery is associated with weight reduction. In addition to that, evidence suggests that gastric bypass surgery has affected glucose metabolism as well. The Morbid Obesity treatment, Bariatric surgery versus Intensive ...

Researchers seek explanation for sustained weight loss after procedure… The mechanism that causes long-term weight loss with gastric bypass surgery is currently unclear. Reduced caloric intake does not provide the entire explanation for why gastric bypass patients maintain long-term weight loss. Previous studies suggests that enhanced energy expenditure might play ...

Elevated serum liver markers may be disease indicator…. Type 2 diabetes and liver disease seem to have a connection; the liver is one of the targets of some common diabetic medications. The body needs the liver to help maintain normal glucose levels. But when the cells in the body become ...

Data establishes effectiveness of semaglutide in treatment of type 2 diabetes…. Novo Nordisk is currently the manufacturer for Victoza (liraglutide), a GLP-1 agonist that needs to be injected once daily. However, semaglutide only needed to be taken once weekly, which is more preferred. The main objective of the SUSTAIN-3 trial ...

Blood glucose showed significant decrease months after procedure… Type 2 diabetes has become more common in today’s society. Currently, modified gastric bypass surgery is used to treat type 2 diabetes. This intervention has been utilized since the 1990s. The procedure reached 83% efficiency and currently the therapeutic mechanism is still ...

Patiromer can normalize moderate hyperkalemia, lower potassium levels in as little as 4 weeks…

A patient, 62 years of age, with type 2 diabetes, obese and with an intellectual disability disorder had been a patient at our clinic for over 10 years. Treatment included metformin and insulin. He met regularly with his endocrinologist and diabetes educator. He spoke often about wanting to lose weight, ...

Overweight and obese patients taking liraglutide (Saxenda) lost more weight than those on placebo… According to a study of 3,731 patients, those on liraglutide lost an average of 8.4±7.3 kg of body weight, and those in the placebo group lost an average of 2.8±6.5 kg (P<0.001). The full results of ...

David Levy, MD, FRCP      Erectile dysfunction This is the commonest neuropathic complication: 20% of men have erectile dysfunction (ED) at diagnosis, increasing to 34% at 12 years (UKPDS). The prevalence in a newly diagnosed Kuwaiti population was 30%, and nearly 50% in a large survey of Canadians attending their primary-care physicians ...